Aurobindo Pharma gets approval for Abacavir Sulfate tabs

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo Pharma gets approval for Abacavir Sulfate tabs

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate tablets 60mg from the US Food & Drug Administration

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab Aurobindo gets approval for Losartan Potassium tabs Aurobindo gets approval for cefazolin for injection USP ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate tablets 60mg from the US Food & Drug Administration (USFDA).

The New Drug Application (NDA) 22-293 provides for the use of Abacavir Sulfate 60mg Tablets in combination with other antiretrovirals for use in pediatric patients for the treatment of HIV-1 infection.

The company had earlier received tentative approvals to Abacavir Sulfate Tablets 300mg and Abacavir Sulfate Oral Solution 20mg/mL

This is Aurobindo's 77th ANDA approval from USFDA. 

Sourced From: Aurobindo Pharma Limited